ArticleCancer discovery2021

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.

James T Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.